Who Exports Clarithromycin from India — 334 Suppliers Behind a $98.4M Market
India's clarithromycin export market is supplied by 334 active exporters who collectively shipped $98.4M across 3,576 shipments. MICRO LABS LIMITED leads with a 20.5% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LIMITED and AUROBINDO PHARMA LTD. The top 5 suppliers together control 55.6% of total export value, reflecting a moderately competitive market structure.
Top Clarithromycin Exporters from India — Ranked by Export Value
MICRO LABS LIMITED is the leading clarithromycin exporter from India, holding a 20.5% share of the $98.4M market across 3,576 shipments from 334 exporters. The top 5 suppliers — MICRO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, AUROBINDO PHARMA LTD, CAPLIN POINT LABORATORIES LIMITED, CIPLA LIMITED — collectively control 55.6% of total export value, indicating a moderately concentrated market. Individual shares are: MICRO LABS LIMITED (20.5%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (16.1%), AUROBINDO PHARMA LTD (7.9%), CAPLIN POINT LABORATORIES LIMITED (5.9%), CIPLA LIMITED (5.1%).
Top Clarithromycin Exporters from India
Ranked by export value · 334 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS USP 500 MG (KLARESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $20.2M | 27 | 20.5% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED CLARITHROMYCIN BASICS TAB 500MG PACK : 1CLARITHROMYCIN TABLETS 500MG PACK : 2X7LANCID KIT PCS | $15.8M | 11 | 16.1% |
| 3 | AUROBINDO PHARMA LTD CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS USP 500 MG (KLARCLARITHROMYCIN TABLETS 500 MG 60'S | $7.8M | 10 | 7.9% |
| 4 | CAPLIN POINT LABORATORIES LIMITED CLARITHROMYCIN TABLETS USP 500MGCLARITHROMYCIN FOR ORAL SUSPENSION USP 2CLARITHROMYCIN FOR INFUSION BP 500 MG CL | $5.8M | 10 | 5.9% |
| 5 | CIPLA LIMITED CLARITHROMYCIN TABLETS USP 500 MG (KLARESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]PYLOKIT [52920X7X1X6'S] | $5.1M | 6 | 5.1% |
| 6 | WEXFORD LABORATORIES PRIVATE LIMITED CLARITHROMYCIN TABLETS USP 500MGCLARITHROMYCIN FOR ORAL SUSPENSION USP 2CLARITHROMYCIN FOR INFUSION BP 500 MG CL | $4.1M | 4 | 4.2% |
| 7 | AJANTA PHARMA LIMITED CLARITHROMYCIN TABLETS USP 500 MG (KLARESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]PHARMACEUTICAL PRODUCT-CLARITHROMYCIN GH500MG CPR B/14 | $4.0M | 9 | 4.1% |
| 8 | LINCOLN PHARMACEUTICALS LTD CLARITHROMYCIN TABLETS USP 500 MG (KLARPYLOKIT [52920X7X1X6'S]PYLOKIT [52653X7X1X6'S] | $4.0M | 3 | 4.0% |
| 9 | AUROBINDO PHARMA LIMITED CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS USP 500 MG (KLARCLARITHROMYCIN TABLETS 500 MG 60'S | $3.6M | 3 | 3.7% |
| 10 | IND SWIFT LIMITED CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN BASICS TAB 500MG PACK : 1CLARITHROMYCIN TABLETS USP 500MG | $2.9M | 23 | 2.9% |
| 11 | MEDLEY PHARMACEUTICALS LIMITED CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS 500 MG 2X7'SCLARITHROMYCIN 500MG TABLETS 02 X 7S B | $1.4M | 2 | 1.4% |
| 12 | MEDICO REMEDIES LIMITED ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]CLARIWELL (CLARITHROMYCIN 250MG/5ML POWDCLARITHROMYCIN 500MG TABLET (CLISTANEX F | $1.3M | 6 | 1.3% |
| 13 | MYLAN LABORATORIES LIMITED | $1.3M | 1 | 1.3% |
| 14 | KOPRAN LIMITED CLARITHROMYCIN TABLETS USP 500 MG (KLARCLARITHROMYCIN TABLETS 500 MGCLARIE OD B.N: EV12424 ,EV12524,MFG: DEC2024 EXP: NOV2028 | $888.1K | 7 | 0.9% |
| 15 | PROSFORA TECHNOLOGIES PRIVATE LIMITED CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS 500 MG 2X7'SCLARITHROMYCIN 500MG TABLETS 02 X 7S B | $794.8K | 1 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Clarithromycin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter, January 2 | Unknown | Unknown | Not verified | Received FDA warning letter for CGMP deviations at Unit I facility. |
| Cipla Limited | Warning Letter, November | Unknown | Unknown | Not verified | Received FDA warning letter for CGMP violations at Indore facility. |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | Not verified | Holds FDA approvals and WHO-GMP, EU GMP certifications. |
| Micro Labs Limited | Approved | Yes | Yes | Not verified | Holds FDA approvals and WHO-GMP, EU GMP certifications. |
| Ajanta Pharma Limited | Approved | Yes | Yes | Not verified | Holds FDA approvals and WHO-GMP, EU GMP certifications. |
| Lincoln Pharmaceuticals Ltd | Approved | Yes | Yes | Not verified | Holds FDA approvals and WHO-GMP, EU GMP certifications. |
| Ind Swift Limited | Approved | Yes | Yes | Not verified | Holds FDA approvals and WHO-GMP, EU GMP certifications. |
| Mylan Laboratories Limited | Approved | Yes | Yes | Not verified | Holds FDA approvals and WHO-GMP, EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 8 leading Clarithromycin exporters from India. 6 hold US FDA facility approvals, 6 maintain WHO-GMP certification, and 6 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Clarithromycin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes to over 40% of the country's bulk drug production. The city hosts numerous manufacturers specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, which are crucial for producing antibiotics such as Clarithromycin. Notable companies include SVK Laboratories Private Limited, established in 2007, which focuses on high-quality bulk drugs and drug intermediates. Additionally, Vasudha Pharma Chem Ltd., located in Jeedimetla, Hyderabad, is recognized for its production of bulk drugs and intermediates.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and contract manufacturing services. This region is home to companies like Alembic Pharmaceuticals, headquartered in Vadodara, which manufactures and markets a range of pharmaceutical products, including APIs and formulations. Additionally, Schwitz Biotech in Ahmedabad specializes in formulating, manufacturing, and exporting a wide range of pharmaceutical formulations, adhering to FDA, WHO, GMP, and ISO 9002 quality standards. The presence of such companies makes this cluster a significant hub for pharmaceutical formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for India's pharmaceutical industry. Its strategic coastal location facilitates efficient international shipping, making it a pivotal point for exporting pharmaceutical products, including antibiotics like Clarithromycin. The region's well-developed infrastructure and proximity to major ports enhance its role in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, largely due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing to its rapid growth in the pharmaceutical sector.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Leverage Regional Specializations: Source APIs from Hyderabad for cost-effective bulk drugs and formulations from Ahmedabad-Vadodara for high-quality finished products.
- Optimize Logistics: Utilize the Mumbai-Thane-Raigad region for efficient export operations, taking advantage of its proximity to major ports.
- Evaluate Cost Benefits: Consider manufacturing in the Baddi-Nalagarh region to benefit from tax incentives, potentially reducing overall production costs.
By strategically sourcing from these specialized clusters, TransData Nexus can enhance the efficiency and resilience of its Clarithromycin supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Clarithromycin exporters from India
Caplin Point Laboratories Limited — Caplin Point acquires 10 approved ANDAs for injectables and ophthalmic products
Caplin Point Laboratories Limited, through its subsidiaries Caplin Steriles Limited and Caplin One Labs Limited, acquired 10 approved Abbreviated New Drug Applications (ANDAs) for injectable and ophthalmic products from a leading multinational generic product manufacturer. The addressable market for these products was $473.2 million for the 12-month period ending August 2025. - IMPACT: This acquisition is expected to enhance Caplin Point's product portfolio, potentially increasing its Clarithromycin export capabilities.
Impact: This acquisition is expected to enhance Caplin Point's product portfolio, potentially increasing its Clarithromycin export capabilities.
Aurobindo Pharma Limited — Aurobindo Pharma acquires Khandelwal Labs' non-oncology branded generics business
Aurobindo Pharma Limited, through its subsidiary Auro Pharma Ltd, acquired the non-oncology branded generic prescription formulations business of Khandelwal Laboratories Pvt Ltd (KLAB). This business includes a portfolio of branded generic products across key therapeutic areas, including pain management, gastrointestinal, and anti-infective treatments. - IMPACT: The acquisition may strengthen Aurobindo Pharma's position in the anti-infective segment, potentially impacting its Clarithromycin exports.
Impact: The acquisition may strengthen Aurobindo Pharma's position in the anti-infective segment, potentially impacting its Clarithromycin exports.
Aurobindo Pharma Limited — USFDA scrutiny delays generic drug approvals for Aurobindo Pharma
Aurobindo Pharma faced intense scrutiny from the US Food and Drug Administration (USFDA), including inspections and warning letters. In May 2024, the company received seven observations for its Unit-II formulation manufacturing facility in Bhiwadi, Rajasthan, and three observations for its new injectable facility in Andhra Pradesh earlier. - IMPACT: Regulatory challenges may affect Aurobindo Pharma's production timelines, potentially impacting Clarithromycin exports.
Impact: Regulatory challenges may affect Aurobindo Pharma's production timelines, potentially impacting Clarithromycin exports.
Common Questions — Clarithromycin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which clarithromycin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MICRO LABS LIMITED leads with 308 recorded shipments worth $20.2M. SUN PHARMACEUTICAL INDUSTRIES LIMITED (309 shipments) and AUROBINDO PHARMA LTD (183 shipments) are also established high-volume exporters.
Q How many clarithromycin manufacturers are there in India?
India has 334 active clarithromycin exporters with a combined export market of $98.4M across 3,576 shipments to 144 countries. The top 5 suppliers hold 55.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for clarithromycin from India?
Average FOB unit price: $64.25 per unit, ranging from $0.00 to $89112.90. Average shipment value: $27.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 334 verified Indian exporters of Clarithromycin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 3,576 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 144 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,576 Verified Shipments
334 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists